Efficacy of tailored Helicobacter pylori eradication therapy based on susceptibility to antimicrobial agents
Not Applicable
Recruiting
- Conditions
- H. pylori-associated gastritis
- Registration Number
- JPRN-UMIN000030270
- Lead Sponsor
- Shiga University of Medical Science Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 310
Inclusion Criteria
Not provided
Exclusion Criteria
1. With malignant diseases 2. Negative for culture test 3. With severe liver disease 4. No informed consent 5. Not suitable by judgement of Medical Doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eradication rate of tailored eradication therapy based on susceptibility to antimicrobial agents.
- Secondary Outcome Measures
Name Time Method 1. Eradication rate of tailored tailored H. pylori eradication therapy based on susceptibility to antimicrobial agents among different CYP2C19, CYP3A4, CYP3A5 genotypes. 2.Change of abdominal symptoms between before and after eradication therapy